https://www.indianpharmapost.com/kahimmune-therapeutics-signs-agreement-for-scientific-collaboration-with-gustave-roussy-199702026-04-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/laguna-diagnostics-secures-fda-breakthrough-tag-for-mrna-test-in-psychiatric-diagnosis-199802026-04-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/nadmed-limited-appoints-james-lee-as-ceo-to-drive-global-expansion-199792026-04-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/cubo-set-to-transform-decentralised-diagnostics-with-compact-rt-pcr-innovation-199782026-04-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-okays-astrazenecas-triple-therapy-breztri-for-asthma-199772026-04-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbvie-seeks-fda-nod-for-rinvoq-use-in-severe-alopecia-areata-199762026-04-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/exciva-initiates-phase-23-serenada-trial-for-alzheimers-agitation-therapy-199752026-04-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/illuminova-26-showcases-ai-driven-future-of-medical-education-at-srm-199742026-04-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/onesource-pharma-dr-reddys-secure-health-canada-nod-for-generic-semaglutide-199732026-04-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/evonik-and-higuchi-launch-open-pharma-lab-in-yokohama-to-accelerate-oral-drug-innovation-199722026-04-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizer-locks-in-long-runway-for-blockbuster-heart-drug-after-key-patent-settlements-199712026-04-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/gleneagles-bgs-hospital-launches-heal-health-card-to-expand-access-to-affordable-care-199692026-04-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/sanofi-consumer-healthcare-reports-33-revenue-growth-in-q1-fy26-pat-rises-36-199682026-04-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/leinco-technologies-and-cellcarta-partner-to-advance-proteomics-in-immuno-oncology-199672026-04-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/granules-india-q4fy26-revenue-jumps-23-to-rs-14706-million-fy26-revenue-at-rs-53656-million-199812026-04-29T00:00:00+05:30always0.9